ExLibris header image
SFX Logo
Title: Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis
Source:

Plos One [1932-6203] yr:2016


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. NAKAMURA, T. "Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase." Proceedings of the Japan Academy. 93.7: 449-463. Link to SFX for this item
2. van Griensven, J. "Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea." The New England Journal of Medicine 374.1 (2016): 33-42. Link to SFX for this item
3. Gubareva, L. "In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses." Antimicrobial agents and chemotherapy 54.6 (2010): 2517-2524. Link to Full Text for this item Link to SFX for this item
4. Furuta, Y. "Mechanism of action of T-705 against influenza virus." Antimicrobial agents and chemotherapy 49.3 (2005): 981-986. Link to Full Text for this item Link to SFX for this item
5. Baranovich, T. "T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses in Vitro." Journal of virology 87.7 (2013): 3741-3751. Link to Full Text for this item Link to SFX for this item
6. Furuta, Y. "T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections." Antiviral research 82.3 (2009): 95-102. Link to SFX for this item
7. Furuta, Y. "In vitro and in vivo activities of anti-influenza virus compound T-705." Antimicrobial agents and chemotherapy 46.4 (2002): 977-981. Link to Full Text for this item Link to SFX for this item
8. Jochmans, D. "Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters." Antimicrobial agents and chemotherapy 60.8 (2016): 4620-4629. Link to Full Text for this item Link to SFX for this item
9. Corti, D. "Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody." Science 351.6279 (2016): 1339-1342. Link to SFX for this item
10. Sissoko, D. "Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea." PLoS Medicine 13.3 (2016): 1-. Link to Full Text for this item Link to SFX for this item
11. Gulland, A. "Clinical trials of Ebola therapies to begin in December." BMJ. British medical journal 349.nov14 4 (2014). Link to SFX for this item
12. Gurwith, M. "Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: A Randomised, double-blind, placebo-controlled, phase 1 study." The Lancet infectious diseases 13.3 (2013): 238-250. Link to SFX for this item
13. Vedula, M. "Novel nucleosides as potent influenza viral inhibitors." Bioorganic & medicinal chemistry 18.17 (2010): 6329-6339. Link to SFX for this item
14. Centers for Disease Control and Prevention (CDC), K A. "2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009." MMWR. Morbidity and Mortality Weekly Report 58.3 (2009): 913-8. Link to SFX for this item
15. Morrey, D. "Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents." Antiviral research 80.3 (2008): 377-379. Link to SFX for this item
16. Leyssen, P. "Molecular strategies to inhibit the replication of RNA viruses." Antiviral research 78.1 (2008): 9-25. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.